Background. Existing severity assessment tools, such as the pneumonia severity index (PSI) and CURB-65 (tool based on confusion, urea level, respiratory rate, blood pressure, and age у65 years), predict 30-day mortality in community-acquired pneumonia (CAP) and have limited ability to predict which patients will require intensive respiratory or vasopressor support (IRVS).
. Characteristics of validation cohort studies. Characteristic PORT [3] CAPO [21] Austin [22] EDCAP [23] LOS [24] a Other exclusion criteria were substance abuse, poor psychosocial circumstances that precluded outpatient therapy, incarceration, homelessness, and pregnancy. b Other exclusion criteria were immunosuppression (i.e., HIV infection, WBC count ! 3000 cells/mm 3 , asplenia, hypogammaglobulinemia, use of myelosuppressive medications, corticosteroid use, or organ transplantation), injection drug use, alcohol abuse, or receipt of only palliative care.
features is converted into a score that indicates the patient's risk of death and can be used to guide the choice of inpatient versus outpatient care. Although 30-day mortality is clearly an important outcome, the vast majority of patients who die of CAP are elderly persons with multiple comorbidities [5, 6] . When such patients are admitted to the hospital, aggressive treatment in the intensive care unit (ICU) is often considered inappropriate, given their poor quality of life and prognosis [7] . Thus, tools that are accurate in predicting mortality are less accurate for identifying patients likely to benefit from admission to the ICU [8] [9] [10] [11] [12] .
The ability to predict which patients will require ICU admission can be difficult because clinicians both overestimate and underestimate the severity of CAP [13, 14] . Patients who require ICU admission consume a large proportion of health care expenditure [2, 15] . Early recognition of such patients could improve outcomes, avoid inappropriate nonadmissions, and potentially lead to a shorter length of ICU stay.
Because criteria for ICU admission vary both between hospitals and between countries, we aimed to assess features specifically associated with receipt of intensive respiratory or vasopressor support (IRVS; i.e., invasive or noninvasive mechanical ventilation or infusions of vasopressors for blood pressure support), rather than simple ICU admission, because these are likely to be objective markers of CAP severity across institutions and health care systems.
The Australian Community-Acquired Pneumonia Study (ACAPS) was a prospective, multicenter, observational study that assessed the etiology, severity markers, and treatment outcomes of a large population of patients with CAP defined by strict criteria [16] . We used these data to develop a new tool to identify patients with CAP who require IRVS.
METHODS
Study design and setting. Patient recruitment and the inclusion and exclusion criteria have been described elsewhere [17] ; the only difference for this aspect of the study is that pregnant patients were excluded from analysis. The following patient details were recorded: demographic characteristics, comorbid illnesses, initial vital signs, and the various investigational results required to calculate PSI [3] and CURB-65 [4] scores. In calculating the PSI score, we allowed the use of pulse oximetry scores р90% to obtain the 10 points for hypoxia [3] and the use of pH from a venous blood sample (30 points for venous pH !7.30) if arterial puncture was thought to be inappropriate, because this correlates with arterial acidosis [18] . On the basis of CURB-65 scores, patients were classified into CURB-65 group 1 (scores 0-1), group 2 (score 2), and group 3 (scores 3-5) [4] . In addition, we recorded other comorbidities (smoking status, asthma, chronic obstructive pulmonary disease [COPD] , diabetes mellitus, alcohol abuse, injection drug use, neuromuscular conditions, epilepsy, or dementia), oral antibiotic and corticosteroid use before hospitalization, vital signs at the time of arrival and the worst results (e.g., highest respiratory rate and lowest blood pressure) in the first 24 h, other initial laboratory results (including WBC count, serum albumin level, erythrocyte sedimentation rate, and C-reactive protein level), and results of urinary antigen tests for Legionella infection (Binax). The number of pulmonary lobes involved and the presence of pleural effusions were assessed on chest radiography. Blood culture specimens were obtained before parenteral administration of antibiotics.
In the hospital, patients were assessed for time to clinical stability [19] , admission to the ICU (including the high dependency unit or coronary care unit), and length of hospital stay. In particular, we recorded the receipt of IRVS as a more objective marker of severity than simple ICU admission. At 4-6 weeks after admission, patients were assessed for cure and for 30-day mortality.
Statistical analysis and development of the severity prediction tool. Univariate analysis was performed using logistic regression to explore associations between patient characteristics and clinical features at the time of admission and the risk of subsequent receipt of IRVS. For multivariate analyses, a pre- liminary step of exploratory analysis was pursued in which the cohort was stratified on age р50 years; separate logistic regression models were developed for older and younger patients, and a small number of different cutoff points were considered for each covariate. This was repeated with stratification on age !40 years. On the basis of these exploratory analyses, definitions of high respiratory rate and hypoxia differed for patients aged 150 years and those aged р50 years, and this concurred with a priori clinical expectations. For patients aged р50 years, tachypnea was defined as a respiratory rate у25 breaths/min; for patients aged 150 years, it was defined as у30 breaths/min. Hypoxia was defined as partial pressure of oxygen (PaO 2 ) !70 mm Hg, PaO 2 divided by the fraction of inspired oxygen (PaO 2 / FiO 2 ) !333, or arterial oxygen saturation (SpO 2 ) р93% for patients aged р50 years and as PaO 2 !60 mm Hg, PaO 2 /FiO 2 !250, or SpO 2 р90% for patients aged 150 years. It was assumed that patients without arterial pH measurements had a normal value [3] . Multivariate logistic regression analyses of the features associated with receipt of IRVS were performed using sex, age р50 years, and all variables that had on univariate anal-P ! .2 ysis, had prevalence 15%, were observed in at least 95% of patients, and would be easily and rapidly ascertainable by hospital clinicians. A backwards stepwise selection procedure was used with removal of variables that had and reinclusion P 1 .1 of variables that had . As a strategy to avoid overfitting, P ! .05 1000 bootstrap replications of the selection procedure were performed, and only variables present in at least 60% of replications were retained in the final multivariate model [20] . A second model was obtained by retaining in the model only those variables that would be easily ascertained in primary care, without laboratory investigations.
The logistic regression model formula was
where , , and so forth were variables, such as hypoxia and X X 1 2 tachycardia, and , , and so forth were the corresponding b b 1 2 "beta" coefficients. The 2 final models were simplified by assigning a score of 1 point to variables with a beta coefficient р1.2 (corresponding to an OR of 3.2) and 2 points to variables with a beta coefficient 11.2 (the so-called minor and major criteria, respectively). All statistical calculations were performed using Stata, version 9 (Stata Corp.). External validation. We calculated scores for the new prediction rules for a total of 7464 patients from 5 existing databases, whose patient enrollment characteristics are shown in table 1 [3, [21] [22] [23] [24] . Area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow goodness-offit statistic were calculated to assess the discriminability and calibration of the derived tools in predicting the need for IRVS.
RESULTS

Patient population for derivation.
Approximately 2500 patients were assessed, and 882 episodes of CAP involving 862 patients were included. The main reasons for exclusion were normal chest radiography, receipt of parenteral antibiotics before obtainment of blood culture specimens, hospitalization within the preceding 2 weeks, or suspected aspiration. Patient demographic characteristics, clinical features (including PSI and CURB-65 scores), and sites of enrollment are shown in table 2.
Need for IRVS and 30-day mortality. Admission to the ICU occurred in 118 (13.4%) of 882 episodes, and IRVS was required in 91 (10.3%) of 882 episodes; of the 91 patients involved, 40 (44.0%) were intubated, 41 (45.1%) received noninvasive ventilation, and 38 (41.8%) received vasopressor support. Of the 91 patients who received IRVS, 53 (58.2%) were admitted to the ICU directly from the emergency department, whereas the remaining 38 (41.8%) were initially admitted to general wards and later were transferred to the ICU.
Overall, the 30-day mortality rate was 5.7% (50 deaths in 882 episodes), and 14 (15.4%) of the 91 patients who required IRVS died. Thus, only 14 (28.0%) of the 50 patients who died within 30 days after hospital admission had been admitted to the ICU; all received IRVS. The remaining patients who died were all designated "not for resuscitation" (NFR) and had active treatment withdrawn.
The performance of the PSI and CURB-65 tools in predicting the need for IRVS and 30-day mortality is shown in table 3. PSI classes IV and V together predicted 67 (73.6%) of the 91 patients who received IRVS. However, 9 (9.9%) of the 91 patients were in PSI classes I and II, and 15 (16.5%) were in PSI class III. In comparison, CURB-65 group 3 predicted the need for IRVS in 35 (38.5%) of the 91 patients, whereas 30 (33.0%) and 26 (28.6%) of the 91 patients were in CURB-65 groups 1 and 2, respectively.
Features associated with IRVS and development of SMART-COP. The features that were associated with IRVS in univariate and multivariate analyses are shown in table 4. In the multivariate analyses of the 849 patients who had complete data available for all variables considered, age, sex, asthma, COPD, smoking status, injection drug use, immunosuppression, low diastolic blood pressure, sodium level, WBC count, and elevated urea level were excluded. On the basis of their beta coefficients, hypoxia, hypotension, and low arterial pH had the strongest associations with IRVS and were major criteria, whereas confusion, tachycardia, tachypnea, multilobar chest radiography involvement, and low serum albumin level were minor criteria. Initials of the 8 features that were associated with the need for IRVS in the final multivariate model were summarized in the mnemonic "SMART-COP" (systolic blood pressure, multilobar chest radiography involvement, albumin level, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH) (figure 1). A modified version of SMART-COP that is suitable for use in primary care settings was created by removing from SMART-COP the need for measurements of albumin level, arterial pH, and PaO 2 . The major criteria (2 points each) in this primary care tool are low systolic blood pressure and hypoxia (based on pulse oximetry results) (figure 1), and the minor criteria (1 point each) are confusion, tachycardia, tachypnea, and multilobar chest radiography involvement. The first initials of these features were summarized in the mnemonic "SMRT-CO" (systolic blood pressure, multilobar chest radiography involvement, respiratory rate, tachycardia, confusion, and oxygenation).
A SMART-COP score of у3 points identified 84 (92.3%) of 91 patients who received IRVS. In comparison, a SMRT-CO score of у2 points identified 82 (90.1%) of the 91 patients. The sensitivities of all 4 tools (SMART-COP, SMRT-CO, PSI, and CURB-65) for predicting receipt of IRVS in the ACAPS cohort are shown in table 5. Receiver operating characteristic curves and AUCs for each tool are shown in figure 2. As shown in figure 3 , an increasing SMART-COP score was associated with an increased rate of receipt of IRVS. An increasing score was also associated with higher mortality, and 42 (84%) of the 50 patients who died had SMART-COP scores у3 points. A SMART-COP score у3 points had a positive predictive value (PPV) of 22.2%, and each subsequent 1-point increase in the score raised the PPV by ∼10% (data not shown).
Of the 53 patients who received IRVS who were admitted directly to the ICU from the emergency department, a SMART-COP score у3 points accurately identified 52 (98.1%). Of the 38 patients transferred from the emergency department to the general ward and later to the ICU, 32 (84.2%) had a SMART-COP score у3 points. Patients who received IRVS but had SMART-COP scores !3 all experienced significant clinical deterioration at least 24-48 h after hospital admission; all but 1 of these patients received noninvasive ventilation.
Validation of SMART-COP. Results of the external validation of SMART-COP are shown in table 6. Overall, AUC Figure 2 . Area under the receiver operating characteristic curve (AUC) analysis for the 4 severity assessment tools. CURB-65, tool based on confusion, urea level, respiratory rate, blood pressure, and age у65 years; PSI, pneumonia severity index. NOTE. AUC, area under the receiver operating characteristic curve; CURB-65, tool based on confusion, urea level, respiratory rate, blood pressure, and age у65 years; NPV, negative predictive value; PPV, positive predictive value; PSI, pneumonia severity index; SMART-COP, prediction tool based on systolic blood pressure, multilobar chest radiography involvement, albumin level, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH; SMRT-CO, prediction tool based on systolic blood pressure, multilobar chest radiography involvement, respiratory rate, tachycardia, confusion, and oxygenation.
analysis indicated good discrimination for SMART-COP scores. There was no evidence of lack of fit in any database, indicating that the prediction probability of SMART-COP for IRVS appeared to be good. Nevertheless, there were some limitations in this validation analysis. Because results for respiratory rate and hypoxia were recorded as binary results in most of these databases (i.e., above or below the relevant cutoff of the PSI), it was generally difficult to assess accurately the lower cutoff levels suggested by SMART-COP and SMRT-CO for these variables for patients aged р50 years [3, 21, 23, 24] . Similarly, serum albumin level and arterial pH were recorded infrequently in the validation cohorts [3, 23, 24] , and we followed the standard of assuming that patients with missing data had normal values [3] . This approach is likely to have resulted in a lower calculated sensitivity for SMART-COP and may explain why SMRT-CO appeared to have similar sensitivity in those databases. Nevertheless, despite these methodological differences in the CAP validation cohort studies, SMART-COP appeared to be a sensitive and specific predictor of patients with CAP who are likely to require IRVS.
DISCUSSION
Current pneumonia severity assessment tools, such as PSI and CURB-65, aim to predict the likely 30-day mortality, but this outcome is heavily dependent on the patient's age and comorbid illnesses, so these tools may not necessarily predict the need for ICU admission or IRVS [8] [9] [10] [11] [12] . In fact, such features may be important to clinicians in determining whether a patient's case should be designated NFR and therefore not appropriate for aggressive medical management. A SMART-COP score of у3 points better identified the majority of patients who received IRVS than did PSI classes IV and V and CURB-65 group 3. SMART-COP was accurate both for patients who went directly to the ICU from the emergency department (sensitivity, 98%) and for those who were initially admitted to the general ward before their condition deteriorated (sensitivity, 84%). Increasing SMART-COP scores were associated with an increasing likelihood of requiring IRVS. Similarly, SMRT-CO, which does not require investigations beyond chest radiography and pulse oximetry, also proved to be an accurate and simple system for identifying patients at a higher risk of severe disease, although less so than SMART-COP. Accuracy of both tools was high for both the derivation and the validation cohorts. The age-adjusted cutoffs for respiratory rate and hypoxia used in these tools are particularly useful for the identification of younger, previously healthy patients with severe CAP. Such patients are better able to increase tidal volume, instead of just respiratory rate, and so may not achieve a rate of 30 breaths/min despite having severe CAP. In addition, their PaO 2 must drop further from baseline to reach !60 mm Hg, compared with that of many elderly patients with preexisting respiratory or cardiac comorbidities.
Although the PSI severity assessment tool is accurate in predicting 30-day mortality, it is cumbersome and therefore less attractive for widespread use [25] [26] [27] . In addition, a patient can be assigned to PSI class V on the basis of their age and NOTE. AUC, area under the receiver operating characteristic curve; CAPO, Community-Acquired Pneumonia Organization; EDCAP, Emergency Department CAP trial; LOS, Length of Stay Project; PORT, Pneumonia Patient Outcomes Research Team; SMART-COP, prediction tool based on systolic blood pressure, multilobar chest radiography involvement, albumin level, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH; SMRT-CO, prediction tool based on systolic blood pressure, multilobar chest radiography involvement, respiratory rate, tachycardia, confusion, and oxygenation.
a Hosmer-Lemeshow goodness-of-fit P value. b Sensitivity and specificity were calculated at SMART-COP and SMRT-CO scores of у3 points and у2 points, respectively.
comorbidities alone, even with clinically mild CAP [3] . Similar to previous studies in which 14%-37% of patients who required ICU admission were in PSI classes I-III [3, [8] [9] [10] 12] , we found that 26% of patients in our study were in PSI classes I-III. CURB-65 has the advantage of simplicity [4, 25, 26] . However, in our population, it had poor sensitivity for predicting 30-day mortality and the need for IRVS, and many patients were categorized incorrectly as low risk. Population differences may partly explain the discrepancy; we had a higher ICU admission rate (13% in ACAPS vs. 5% in the original CURB-65 study), and we included patients who are nursing home residents [4] . The discriminatory power of CURB-65 appears to be reduced by the use of cutoffs for diastolic blood pressure of р60 mm Hg and for serum urea level of only 7 mmol/L (table 2) . Thus, many elderly patients are classified as having severe disease (CURB-65 group 3) on the basis of their age and minimally abnormal readings of diastolic blood pressure and urea level.
Several previous studies have compared existing severity assessment systems, such as PSI and CURB-65, for their ability to predict ICU admission [11, 12, 28] . Capelastegui et al. [11] found similar AUC results for the 2 systems. However, CURB-65 group 3 identified only 33% of those admitted to the ICU and 39% of those who received mechanical ventilation [11] . Buising et al. [12] compared these and other systems and found that none of these tools were ideal for predicting ICU admission and that a modified version of the British Thoracic Society rule performed better, although it was equivalent to the PSI when only patients with confirmed CAP were assessed [12] . Both studies were limited by the small numbers of ICU patients (26 and 45 patients). In addition, each author group found that AUC results were similar for CURB-65 and PSI, because of the better sensitivity and inferior specificity of PSI [11, 12] . Because most clinicians consider a test with high sensitivity to be preferable in serious situations, such as for patients who require IRVS, such equivalence of AUC results may lack clinical relevance. More recently, España et al. [29] developed a new prediction tool that is designed to predict both IRVS and death. However, this tool includes the criteria of age у80 years, severe hypoxia (PaO 2 !54 mm Hg or PaO 2 /FiO 2 !250) and tachypnea (respiratory rate, 130 breaths/min); thus, this tool is likely to have poor sensitivity for younger patients. Among ACAPS participants, this tool had a sensitivity of 37% and specificity of 90%.
Our study has some limitations. First, nearly all ACAPS patients were admitted to the hospital; thus, the study included smaller numbers of patients in PSI classes I and II. Second, although we recruited patients from 6 centers, the majority of patients were recruited from 3 large, urban teaching hospitals. Thus, we cannot be certain that similar findings would be noted in a more diverse patient population. Third, comparison with other previous studies is somewhat difficult because our key severity outcome measure was receipt of IRVS, rather than simple ICU admission. However, we believe that IRVS is a more robust end point because it avoids possible confounding associated with differences in ICU admission criteria. Finally, the external validation of SMART-COP and SMRT-CO was complicated by the absence of some data and the binary nature of some variables in these databases. Nevertheless, these databases represent the best available and have been used to develop and validate the PSI and other severity tools. On the basis of our analysis, SMART-COP and SMRT-CO appeared to be highly accurate among this very large, nonderivation cohort of 17000 patients.
In conclusion, SMART-COP is a new, relatively simple, 8-variable tool that appears to identify accurately patients with CAP who will require IRVS. Our findings suggest that SMART-COP is likely to be a useful advance for clinicians in the accurate prediction of disease severity among patients with CAP.
